CollPlant Biotechnologies Ltd. (CLGN)
0.3203
-0.02
(-6.70%)
USD |
NASDAQ |
Sep 03, 16:00
0.344
+0.02
(+7.40%)
After-Hours: 18:12
CollPlant Biotechnologies Market Cap : 4.620M for Sept. 3, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 02, 2026 | 4.952M |
| September 01, 2026 | 5.374M |
| August 31, 2026 | 5.595M |
| August 28, 2026 | 5.164M |
| August 27, 2026 | 4.178M |
| August 26, 2026 | 4.435M |
| August 25, 2026 | 4.183M |
| August 24, 2026 | 4.338M |
| August 21, 2026 | 4.507M |
| August 20, 2026 | 4.584M |
| August 19, 2026 | 4.641M |
| August 18, 2026 | 4.535M |
| August 17, 2026 | 4.611M |
| August 14, 2026 | 4.755M |
| August 13, 2026 | 4.595M |
| August 12, 2026 | 4.605M |
| August 11, 2026 | 4.255M |
| August 10, 2026 | 4.686M |
| August 07, 2026 | 4.887M |
| August 06, 2026 | 4.770M |
| August 05, 2026 | 4.473M |
| August 04, 2026 | 4.137M |
| August 03, 2026 | 4.587M |
| July 31, 2026 | 3.935M |
| July 30, 2026 | 4.326M |
| Date | Value |
|---|---|
| July 29, 2026 | 4.500M |
| July 28, 2026 | 4.728M |
| July 27, 2026 | 4.600M |
| July 24, 2026 | 4.540M |
| July 23, 2026 | 4.506M |
| July 22, 2026 | 4.616M |
| July 21, 2026 | 4.616M |
| July 20, 2026 | 4.504M |
| July 17, 2026 | 4.832M |
| July 16, 2026 | 4.895M |
| July 15, 2026 | 5.032M |
| July 14, 2026 | 5.264M |
| July 13, 2026 | 5.110M |
| July 10, 2026 | 5.308M |
| July 09, 2026 | 5.195M |
| July 08, 2026 | 5.298M |
| July 07, 2026 | 5.192M |
| July 06, 2026 | 6.170M |
| July 02, 2026 | 4.907M |
| July 01, 2026 | 4.908M |
| June 30, 2026 | 5.032M |
| June 29, 2026 | 5.288M |
| June 26, 2026 | 4.799M |
| June 25, 2026 | 4.902M |
| June 24, 2026 | 4.852M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Anika Therapeutics, Inc. | 281.18M |
| Perspective Therapeutics, Inc. | 354.81M |
| MiMedx Group, Inc. | 644.10M |
| Regentis Biomaterials Ltd. | 10.26M |
| Xylo Technologies Ltd. | 4.089M |
Market Cap Related Metrics
| PS Ratio | 10.52 |
| Price to Book Value | 0.9455 |
| Price | 0.3203 |
| Earnings Yield | -322.3% |